Besides, a startup needs to be aged 11-15 years to get the investment from the fund. Among the most popular fund investment industries, there are Medical, Manufacturing. Among the most popular portfolio startups of the fund, we may highlight Addex Therapeutics, Medigus.
The overall number of key employees were 1.
The usual cause for the fund is to invest in rounds with 3-4 partakers. Despite the Armistice Capital, startups are often financed by Varuma AG, Sofinnova Partners, SR One. The meaningful sponsors for the fund in investment in the same round are Senvest Capital, Sabby Management, OrbiMed. In the next rounds fund is usually obtained by Hercules Bioventure Partners, Michael J. Fox Foundation.
Deals in the range of 5 - 10 millions dollars are the general things for fund. The fund is constantly included in less than 2 deals per year. The higher amount of exits for fund were in 2018. The high activity for fund was in 2013.
Related Funds
| Fund Name | Location |
| Astmax | Japan, Tokyo |
| D.Phone | Beijing, Beijing, China |
| ICT Group N.V. | Barendrecht, The Netherlands, Zuid-Holland |
| Innovative Medicines Initiative | Belgium, Berchem, Brussels-Capital |
| InnoWerft | Baden-Wurttemberg, Germany, Walldorf |
| Kunda Technology | - |
| Liberty Israel Venture Fund | Israel, Tel Aviv, Tel Aviv District |
| Likang Zhihui Yiliao | Baoshan, China, Shanghai |
| LiquidPrice.com | California, Cupertino, United States |
| Londonderry Management | New York, New York, United States |
| Molex Ventures | Illinois, Lisle, United States |
| New Avenue Capital | - |
| Noble Partners | - |
| Shikong Wuxing | China, Shanghai |
| Taya Investment Company Ltd | - |
| Teikoku Databank | Japan, Tokyo |
| The Kiyo Lease & Capital | Japan, Wakayama, Wakayama Prefecture |
| Times Internet | Gurgaon, Haryana, India |
| TowerComm | North Carolina, Raleigh, United States |
| Whitefish Ventures | Minnesota, Minnesota City, United States |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data 